Myriad Genetics (MYGN) Free Cash Flow Growth (1y) (2010 - 2026)
Myriad Genetics (MYGN) Free Cash Flow Growth (1y) (2010 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Thermo Fisher Scientific | 213.44 Bn | 209.37 Bn | 8.34 Bn | 51.58% |
| 2 | Danaher | 139.95 Bn | 135.60 Bn | 3.61 Bn | 16.06% |
| 3 | Idexx Laboratories | 46.16 Bn | 45.96 Bn | 779.09 Mn | 112.68% |
| 4 | Agilent Technologies | 39.67 Bn | 37.87 Bn | 990.00 Mn | 87.85% |
| 5 | Iqvia Holdings | 39.29 Bn | 37.21 Bn | 1.44 Bn | 23.29% |
| 6 | Natera | 38.61 Bn | 37.51 Bn | 696.04 Mn | -20.33% |
| 7 | Illumina | 29.99 Bn | 28.82 Bn | 770.00 Mn | -21.08% |
| 8 | Mettler Toledo International | 28.57 Bn | 28.51 Bn | 650.22 Mn | 33.01% |
| 9 | Quest Diagnostics | 26.17 Bn | 25.55 Bn | 1.03 Bn | 5.28% |
| 10 | Myriad Genetics | 296.09 Mn | 171.69 Mn | 137.60 Mn | 2.31% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 2.31% |
| Dec 31, 2025 | 96.67% |
| Sep 30, 2025 | 439.29% |
| Jun 30, 2025 | 20.00% |
| Mar 31, 2025 | -17.39% |
| Dec 31, 2024 | 106.32% |
| Sep 30, 2024 | 90.24% |
| Jun 30, 2024 | -142.04% |
| Mar 31, 2024 | 67.55% |
| Dec 31, 2023 | -116.89% |
| Sep 30, 2023 | -40.00% |
| Jun 30, 2023 | 140.07% |
| Mar 31, 2023 | -7.39% |
| Dec 31, 2022 | -69.77% |
| Sep 30, 2022 | 59.96% |
| Mar 31, 2022 | -181.61% |
| Dec 31, 2021 | 84.19% |
| Sep 30, 2021 | 15.37% |
| Mar 31, 2021 | 368.84% |
| Dec 31, 2020 | -457.89% |